Pioneering the Next Era in Personalized Medicine FAMILY FOUNDATION ENDOWS LEVINE CANCER INSTITUTE
A
new era in personalized therapies for cancer is being ushered in with support from generous community benefactors. A lead gift of $1 million from Gayle and Charles “Carl” Tallardy III has established the Gayle J. and Charles C. Tallardy III Foundation Distinguished Chair in Clinical Research Endowment at Levine Cancer Institute. David M. Foureau, PhD – associate professor of medicine and research group director of LCI’s Immune Monitoring Core Laboratory – is the first recipient of this chairmanship.
14
MOMENTUM
•
SPRING 2022
|
A T R I U M H E A LT H F O U N D A T I O N
“We look at this gift and the establishment of our endowment as the beginning of a long relationship with Levine Cancer Institute,” shares Carl, pictured with his wife Gayle (above).
